Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $7.13B | $45.37 | -0.31% | $49.69M | 283.56x | 1.60 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.13B | $8.20 | -0.49% | $31.73M | 205.00x | 0.46 | Canada | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $7.54B | $71.48 | -0.56% | $136.81M | 52.95x | 0.24 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $4.77B | $165.69 | -2.47% | $102.07M | 53.11x | 0.12 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $587.79M | $7.56 | -3.69% | $10.34M | 68.73x | 0.48 | United States | ||
| SPRY | ARS PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.39B | $14.16 | 1.36% | $8.37M | 177.00x | 0.37 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $874.34M | $9.34 | -4.30% | $19.63M | 66.71x | 0.43 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $38.88B | $639.90 | -0.81% | $114.32M | 42.29x | 0.13 | Belgium | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.95B | $24.27 | -0.08% | $254.32M | 17.59x | 0.17 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.71B | $29.86 | 1.32% | $233.41M | 11.66x | 0.52 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.89B | $37.92 | -0.26% | $23.28M | 180.57x | 0.48 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $10.88B | $38.89 | -0.66% | $737.90M | 21.61x | 0.31 | United States | ||
| SRPT | SAREPTA THERAPEUTICS INC | NASDAQ | Biotechnology | $6.09B | $62.78 | 0.61% | $314.67M | 25.42x | 1.59 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $7.39B | $60.03 | -2.26% | $656.54M | 17.15x | 4.67 | United States | ||
| RIGL | RIGEL PHARMACEUTICALS INC | NASDAQ | Biotechnology | $334.39M | $18.72 | -4.29% | $28.51M | 18.91x | 48.87 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $18.72B | $32.48 | -1.04% | $1.08B | 16.92x | 0.76 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $292.90B | $65.60 | -1.28% | $20.43B | 20.72x | 2.25 | Denmark | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $5.53B | $23.27 | -2.23% | $147.69M | 27.38x | 0.40 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $12.01B | $62.03 | -1.01% | $406.83M | 213.90x | 0.57 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $933.48M | $6.32 | -8.14% | $63.32M | 23.41x | 0.33 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.50B | $4.95 | -1.79% | $77.54M | 49.50x | -6.00 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.32B | $29.71 | -2.59% | $54.16M | 92.84x | 0.11 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $11.96B | $62.71 | -1.54% | $650.86M | 27.87x | 0.24 | United States | ||
| GNFT | GENFIT SA | NASDAQ | Biotechnology | $203.98M | $4.08 | -0.37% | $9.48M | 120.00x | 1.19 | France | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $7.12B | $117.18 | 0.19% | $1.37B | 12.93x | 1.93 | Ireland | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $7.85B | $49.63 | -1.43% | $312.12M | 49.63x | 0.29 | United States | ||
| ACAD | ACADIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.43B | $14.57 | -0.21% | $273.96M | 10.64x | 0.62 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $13.85B | $20.93 | -1.04% | $1.61B | 12.26x | 0.25 | Denmark | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $13.25B | $293.85 | -3.05% | $1.68B | 10.85x | 0.14 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $63.70B | $590.00 | -1.46% | $5.53B | 14.12x | 0.28 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.